This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from the CADTH pharmaceutical reviews portfolio. Updates on other relevant CADTH initiatives will also be provided. As well, the session includes an open forum, where attendees can direct questions to CADTH President and CEO Suzanne McGurn and other senior staff at CADTH.
The session will be presented in English and can be attended via Zoom webinar. To participate, please register (there is no cost). After registering, you will receive a confirmation email with information about how to join the webinar.
Questions may be sent by email to Events@cadth.ca.